Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Medicine, Brentuximab vedotin, Internal medicine, Autologous stem-cell transplantation, Neutropenia, Salvage therapy, Transplantation, Surgery, Regimen, Adverse effect, Febrile neutropenia, Lymphoma, Oncology, Chemotherapy, Hodgkin lymphoma